1. Home
  2. XOMA

as 07-26-2024 4:00pm EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

Founded: N/A Country:
United States
United States
Employees: N/A City: EMERYVILLE
Market Cap: 336.1M IPO Year: N/A
Target Price: $57.00 AVG Volume (30 days): 36.0K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.92 EPS Growth: N/A
52 Week Low/High: $13.48 - $30.36 Next Earning Date: 08-06-2024
Revenue: $5,811,000 Revenue Growth: 73.10%
Revenue Growth (this year): 349.94% Revenue Growth (next year): 28.50%

XOMA Daily Stock ML Predictions

Share on Social Networks: